U
NPSP

UBS’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

UBS’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$70K Sell
2,700
-86,600
-97% -$2.49M ﹤0.01% 6430
2014
Q2 		$2.95M Buy
89,300
+87,600
+5,153% +$2.53M ﹤0.01% 2496
2014
Q1 		$51K Buy
1,700
+300
+21% +$10.3K ﹤0.01% 6812
2013
Q4 		$43K Sell
1,400
-3,900
-74% -$107K ﹤0.01% 7170
2013
Q3 		$169K Buy
5,300
+200
+4% +$4.59K ﹤0.01% 5389
2013
Q2 		$77K Buy
+5,100
New +$70.7K ﹤0.01% 6222

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's NPSP Position: Q3 2014 in Review

UBS increased its NPS PHARMACEUTICALS INC (NPSP) stake by 36% in Q3 2014, buying an estimated $569K and bringing the position to 74,298 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

UBS first reported a position in NPSP in Q2 2013 and has held it in 6 quarters since. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • UBS held 74,298 shares of NPS PHARMACEUTICALS INC worth $1.93M as of Q3 2014.
  • UBS bought 19,798 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $569K.
  • NPS PHARMACEUTICALS INC made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2938 holding.
  • UBS first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and has held it in 6 quarters since.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.